HCPCS Codes Similar to S0174

HCPCS Codes Similar to “S0174” Code.
Dolasetron mesylate, oral 50 mg (for circumstances falling under the medicare statute, use q0180)

Q0180 Dolasetron mesylate, 100 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 24 hour dosage regimen Code added date: 19980401 Code effective date: 19980401 TXT \| PDF \| XML \| JSON	J1260 Injection, dolasetron mesylate, 10 mg Code added date: 19990101 Code effective date: 20000101 TXT \| PDF \| XML \| JSON
S0091 Granisetron hydrochloride, 1 mg (for circumstances falling under the medicare statute, use q0166) Code added date: 20020101 Code effective date: 20010701 TXT \| PDF \| XML \| JSON	S0119 Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) Code added date: 20120101 Code effective date: 20120101 TXT \| PDF \| XML \| JSON
S0183 Prochlorperazine maleate, oral, 5 mg (for circumstances falling under the medicare statute, use q0164) Code added date: 20020101 Code effective date: 20150101 TXT \| PDF \| XML \| JSON	G0559 Post-operative follow-up visit complexity inherent to evaluation and management services addressing surgical procedure(s), provided by a physician or qualified health care professional who is not the practitioner who performed the procedure (or in the same group practice) and is of the same or of a different specialty than the practitioner who performed the procedure, within the 90-day global period of the procedure(s), once per 90-day global period, when there has not been a formal transfer of care and requires the following required elements, when possible and applicable: reading available surgical note to understand the relative success of the procedure, the anatomy that was affected, and potential complications that could have arisen due to the unique circumstances of the patient's operation. research the procedure to determine expected post-operative course and potential complications (in the case of doing a post-op for a procedure outside the specialty). evaluate and physically examine the patient to determine whether the post-operative course is progressing appropriately. communicate with the practitioner who performed the procedure if any questions or concerns arise. (list separately in addition to office/outpatient evaluation and management visit, new or established) Code added date: 20250101 Code effective date: 20250101 TXT \| PDF \| XML \| JSON
TC Technical component; under certain circumstances, a charge may be made for the technical component alone; under those circumstances the technical component charge is identified by adding modifier 'tc' to the usual procedure number; technical component charges are institutional charges and not billed separately by physicians; however, portable x-ray suppliers only bill for technical component and should utilize modifier tc; the charge data from portable x-ray suppliers will then be used to build customary and prevailing profiles Code added date: 19840101 Code effective date: 19970101 TXT \| PDF \| XML \| JSON	J0200 Injection, alatrofloxacin mesylate, 100 mg Code added date: 20000101 Code effective date: 20160101 TXT \| PDF \| XML \| JSON
J0515 Injection, benztropine mesylate, per 1 mg Code added date: 19820101 Code effective date: 19970101 TXT \| PDF \| XML \| JSON	J0895 Injection, deferoxamine mesylate, 500 mg Code added date: 19920101 Code effective date: 20010101 TXT \| PDF \| XML \| JSON
J1110 Injection, dihydroergotamine mesylate, per 1 mg Code added date: 19820101 Code effective date: 20190101 TXT \| PDF \| XML \| JSON	J2760 Injection, phentolamine mesylate, up to 5 mg Code added date: 19820101 Code effective date: 19970101 TXT \| PDF \| XML \| JSON
J3486 Injection, ziprasidone mesylate, 10 mg Code added date: 20040101 Code effective date: 20040101 TXT \| PDF \| XML \| JSON	J9179 Injection, eribulin mesylate, 0.1 mg Code added date: 20120101 Code effective date: 20120101 TXT \| PDF \| XML \| JSON